Retatrutide
Retatrutide is a triple agonist at GLP-1, GIP, and glucagon receptors studied for unprecedented weight-loss magnitude in metabolic disease research. Investigations map receptor co-activation, energy expenditure via glucagon, and cardiovascular risk biomarker changes.
For in vitro and laboratory research only. Not for human or veterinary administration. Not evaluated by the FDA.
Variants & Pricing
RT5
Peptide5mg × 10 vials (kit)
$100
RT10
Peptide10mg × 10 vials (kit)
$170
RT15
Peptide15mg × 10 vials (kit)
$215
RT20
Peptide20mg × 10 vials (kit)
$250
RT30
Peptide30mg × 10 vials (kit)
$300
RT40
Peptide40mg × 10 vials (kit)
$350
RT50
Peptide50mg × 10 vials (kit)
$400
RT60
Peptide60mg × 10 vials (kit)
$470
To request this compound, join Discord and open a ticket with the product code and variant.
Order via Discord